Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Autoantibodies have been detected in sera before diagnosis of cancer leading to interest in their potential as screening/early detection biomarkers. As we have found autoantibodies to MUC1 glycopeptides to be elevated in early-stage breast cancer patients, in this study we analysed these autoantibodies in large population cohorts of sera taken before cancer diagnosis.
Originalsprog | Engelsk |
---|---|
Tidsskrift | B J C |
Vol/bind | 108 |
Udgave nummer | 10 |
Sider (fra-til) | 2045-55 |
Antal sider | 11 |
ISSN | 0007-0920 |
DOI | |
Status | Udgivet - 28 maj 2013 |
ID: 47682907